NervGen (NGEN:CA): Modulating Immune Cells For Spinal Cord Injury, MS And Parkinson’s
magicmineThesis NervGen (OTCQX:NGENF)(TSXV:NGEN:CA) is a Canadian clinical stage biotech company with one lead drug candidate, NVG-291, to treat several neurodegenerative ...